Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis

Journal of the American College of Cardiology

Volumn 69, Issue 13, 2017, Pages 1653-1665

  Belkaya, Serkan ^a   Kontorovich, Amy R ^b   Byun, Minji ^a   Mulero Navarro, Sonia ^b   Bajolle, Fanny ^c   Cobat, Aurelie ^d   Josowitz, Rebecca ^b   Itan, Yuval ^a   Quint, Raphaelle ^a   Lorenzo, Lazaro ^d   Boucherit, Soraya ^c,d   Stoven, Cecile ^e   Di Filippo, Sylvie ^f   Abel, Laurent ^a,c,d   Zhang, Shen Ying ^a,c,d   Bonnet, Damien ^c   Gelb, Bruce D ^b   Casanova, Jean Laurent ^a,c,d,g  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d IMAGINE INSTITUTE   (France)

^e Reunion CHU   (France)

^f LOUIS PRADEL HOSPITAL   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

cardiomyocytes; children; genetics; immunity; sequencing; virus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; RYANODINE RECEPTOR 2; SODIUM CHANNEL NAV1.5; STAT1 PROTEIN; TOLL LIKE RECEPTOR 3; STAT1 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN;

ACUTE VIRAL MYOCARDITIS; ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE CARDIOMYOPATHY; AUTOSOMAL RECESSIVE DISORDER; BAG3 GENE; CARDIAC MUSCLE CELL; CARDIOMYOPATHY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COXSACKIE VIRUS B3 INFECTION; COXSACKIE VIRUS INFECTION; DISEASE ASSOCIATION; DSP GENE; FEMALE; GENE; GENE SEQUENCE; GENETIC VARIATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; IFNA GENE; IFNB GENE; INDUCED PLURIPOTENT STEM CELL; INFANT; LIMIT OF QUANTITATION; MALE; PKP2 GENE; RYR2 GENE; SCN5A GENE; STAT1 GENE; TLR3 GENE; TNNI3 GENE; VIRUS MYOCARDITIS; CASE CONTROL STUDY; COMPLICATION; ENTEROVIRUS B; GENETICS; HOST PATHOGEN INTERACTION; MYOCARDITIS; PHYSIOLOGY; VIROLOGY;

CARDIOMYOPATHIES; CASE-CONTROL STUDIES; ENTEROVIRUS B, HUMAN; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MYOCARDITIS; MYOCYTES, CARDIAC; STAT1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 3;

EID: 85016460270     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.01.043     Document Type: Article

References (39)

1. 1 Levine, M.C., Klugman, D., Teach, S.J., Update on myocarditis in children. Curr Opin Pediatr 22 (2010), 278–283.
2. 2 Towbin, J.A., Lowe, A.M., Colan, S.D., et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296 (2006), 1867–1876.
3. 3 Herskowitz, A., Wolfgram, L.J., Rose, N.R., Beisel, K.W., Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. J Am Coll Cardiol 9 (1987), 1311–1319.
4. 4 Wiltshire, S.A., Leiva-Torres, G.A., Vidal, S.M., Quantitative trait locus analysis, pathway analysis, and consomic mapping show genetic variants of Tnni3k, Fpgt, or H28 control susceptibility to viral myocarditis. J Immunol 186 (2011), 6398–6405.
5. 5 Casanova, J.L., Human genetic basis of interindividual variability in the course of infection. Proc Natl Acad Sci U S A 112 (2015), E7118–E7127.
6. 6 Casanova, J.L., Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc Natl Acad Sci U S A 112 (2015), E7128–E7137.
7. 7 Bousfiha, A., Jeddane, L., Al-Herz, W., et al. The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol 35 (2015), 727–738.
8. 8 Gorbea, C., Makar, K.A., Pauschinger, M., et al. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem 285 (2010), 23208–23223.
9. 9 Deonarain, R., Cerullo, D., Fuse, K., Liu, P.P., Fish, E.N., Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110 (2004), 3540–3543.
10. 10 Negishi, H., Osawa, T., Ogami, K., et al. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci U S A 105 (2008), 20446–20451.
11. 11 Chapgier, A., Wynn, R.F., Jouanguy, E., et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol 176 (2006), 5078–5083.
12. 12 Guo, Y., Audry, M., Ciancanelli, M., et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med 208 (2011), 2083–2098.
13. 13 Josowitz, R., Mulero-Navarro, S., Rodriguez, N.A., et al. Autonomous and non-autonomous defects underlie hypertrophic cardiomyopathy in BRAF-mutant hiPSC-derived cardiomyocytes. Stem Cell Reports 7 (2016), 355–369.
14. 14 Aretz, H.T., Billingham, M.E., Edwards, W.D., et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1 (1987), 3–14.
15. 15 Raimondi, F., Iserin, F., Raisky, O., et al. Myocardial inflammation on cardiovascular magnetic resonance predicts left ventricular function recovery in children with recent dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging 16 (2015), 756–762.
16. 16 Sharma, A., Marceau, C., Hamaguchi, R., et al. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform. Circ Res 115 (2014), 556–566.
17. 17 Stojdl, D.F., Lichty, B.D., tenOever, B.R., et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4 (2003), 263–275.
18. 18 Cho, H.J., Ma, J.S., Left ventricular non-compaction progression to dilated cardiomyopathy following acute myocarditis in an early infant twin. Minerva Pediatr 67 (2015), 199–202.
19. 19 Lopez-Ayala, J.M., Pastor-Quirante, F., Gonzalez-Carrillo, J., et al. Genetics of myocarditis in arrhythmogenic right ventricular dysplasia. Heart Rhythm 12 (2015), 766–773.
20. 20 Mavrogeni, S., Papavassiliou, A., Cokkinos, D.V., Myocarditis in a patient with Duchenne muscular dystrophy detected by cardiovascular magnetic resonance and cardiac biopsy. Int J Cardiol 132 (2009), e123–e124.
21. 21 van der Zwaag, P.A., Jongbloed, J.D., van den Berg, M.P., et al. A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Hum Mutat 30 (2009), 1278–1283.
22. 22 Hershberger, R.E., Lindenfeld, J., Mestroni, L., et al. Genetic evaluation of cardiomyopathy–a Heart Failure Society of America practice guideline. J Card Fail 15 (2009), 83–97.
23. 23 Wilde, A.A., Behr, E.R., Genetic testing for inherited cardiac disease. Nat Rev Cardiol 10 (2013), 571–583.
24. 24 Itan, Y., Shang, L., Boisson, B., et al. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat Methods 13 (2016), 109–110.
25. 25 Kircher, M., Witten, D.M., Jain, P., O'Roak, B.J., Cooper, G.M., Shendure, J., A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46 (2014), 310–315.
26. 26 Stenson, P.D., Mort, M., Ball, E.V., Shaw, K., Phillips, A., Cooper, D.N., The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133 (2014), 1–9.
27. 27 Fung, G., Luo, H., Qiu, Y., Yang, D., McManus, B., Myocarditis. Circ Res 118 (2016), 496–514.
28. 28 Pollack, A., Kontorovich, A.R., Fuster, V., Dec, G.W., Viral myocarditis—diagnosis, treatment options, and current controversies. Nat Rev Cardiol 12 (2015), 670–680.
29. 29 Pophal, S.G., Sigfusson, G., Booth, K.L., et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 34 (1999), 2105–2110.
30. 30 Chow, L.H., Radio, S.J., Sears, T.D., McManus, B.M., Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 14 (1989), 915–920.
31. 31 Andreoletti, L., Leveque, N., Boulagnon, C., Brasselet, C., Fornes, P., Viral causes of human myocarditis. Arch Cardiovasc Dis 102 (2009), 559–568.
32. 32 Neilson, D.E., Adams, M.D., Orr, C.M., et al. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet 84 (2009), 44–51.
33. 33 Frustaci, A., Verardo, R., Caldarulo, M., Acconcia, M.C., Russo, M.A., Chimenti, C., Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration. Eur Heart J 28 (2007), 733–740.
34. 34 Mavrogeni, S., Markousis-Mavrogenis, G., Papavasiliou, A., Kolovou, G., Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol 7 (2015), 410–414.
35. 35 Bowles, N.E., Ni, J., Marcus, F., Towbin, J.A., The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 39 (2002), 892–895.
36. 36 Campuzano, O., Fernandez-Falgueras, A., Sarquella-Brugada, G., et al. A genetically vulnerable myocardium may predispose to myocarditis. J Am Coll Cardiol 66 (2015), 2913–2914.
37. 37 Eleftherianos, I., Won, S., Chtarbanova, S., et al. ATP-sensitive potassium channel (K(ATP))-dependent regulation of cardiotropic viral infections. Proc Natl Acad Sci U S A 108 (2011), 12024–12029.
38. 38 Lim, B.K., Peter, A.K., Xiong, D., et al. Inhibition of Coxsackievirus–associated dystrophin cleavage prevents cardiomyopathy. J Clin Invest 123 (2013), 5146–5151.
39. 39 Xiong, D., Lee, G.H., Badorff, C., et al. Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease. Nat Med 8 (2002), 872–877.